[Podcast] Bio2040 interviews M4K Pharma's Owen Roberts In a podcast interview with Bio2040, CEO Owen Roberts discusses M4K Pharma's business model and why open science and sharing can be the path to finding medicines for rare diseases like DIPG.
Video recording of M4K's March Scientific Update meeting! Listen to M4K Pharma's virtual Scientific Update Meeting from March 7th, 2018 where our scientists and collaborators discussed the latest progress in M4K's Medicines4Kids project for diffuse intrinsic pontine gliomas (DIPG). Everyone is invited to see the chemistry first-hand! https://youtu.be/Ip-2QVhmhZc
Listen to a recording of the February Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from February 6th, 2018 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are developing [...]
